Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Rela

biospaceDecember 28, 2017

Tag: Agios Pharmaceuticals , NDA

PharmaSources Customer Service